Vimian Group AB: Humanization and Aging Pets Favor Demand in the Animal Health Sector!

The Vimian Group AB follows a dual business model based on a combination of organic growth and acquisition-driven expansion in various segments of the highly fragmented animal health market. The core business of the Vimian Group is divided into four specialized segments, each covering different areas of the animal health market. These include Specialty Pharma, which is the largest segment contributing 44% of revenue in Q3, MedTech, which accounts for 36% of revenue, Veterinary Services, comprising 15% of the revenue contribution, and Diagnostics...